LSA
TEVA icon

Leonteq Securities AG’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Leonteq Securities AG’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-210,000
Closed -$2.03M – 1101
2020
Q4 		$2.03M Buy
+210,000
New +$2.01M 0.11% 161

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Leonteq Securities AG's TEVA Position: Q2 2026 in Review

Leonteq Securities AG reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 83% in Q2 2026, selling an estimated $169K and leaving 1,063 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #866.

Leonteq Securities AG first reported a position in TEVA in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.34M in Q3 2023. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Leonteq Securities AG held 1,063 shares of Teva Pharmaceutical Industries Limited worth $36K as of Q2 2026.
  • Leonteq Securities AG sold 5,084 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $169K.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #866 holding.
  • Leonteq Securities AG first reported a position in Teva Pharmaceutical Industries Limited in Q4 2020 and has held it in 22 quarters since.
  • Leonteq Securities AG's Teva Pharmaceutical Industries Limited position peaked at $3.34M in Q3 2023.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.